Form 4: BIO-key International Director Receives Restricted Stock Grant

Kwok Fong Wong, a Director and Managing Director of BIO-key HK, was granted 2,000 shares of restricted common stock under the company's 2023 Stock Incentive Plan.

Summary

• Kwok Fong Wong, a Director and Managing Director of BIO-key HK, acquired 2,000 shares of BIO-KEY INTERNATIONAL INC (BKYI) common stock on May 27, 2025.
• These shares were granted as restricted stock under the Issuer's 2023 Stock Incentive Plan at a price of $0 per share.
• The restricted stock is set to vest in three equal annual installments on each of the next three anniversaries of the grant date.
• Vesting is contingent upon Mr. Wong's continued employment with or service to the Issuer through the applicable vesting date.
• Following this transaction, Mr. Wong beneficially owns 35,248 shares of common stock.
• This reported holding does not include options to purchase an additional 232 shares.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a key director and officer is a positive sign of management alignment and retention, though it's a routine compensation event rather than a major strategic announcement that would significantly alter the company's financial position or outlook.

Positives

• The grant of restricted stock aligns management's interests with long-term shareholder value by tying compensation to future performance and continued service.
• The multi-year vesting schedule encourages the retention of key personnel, such as Mr. Kwok Fong Wong, who holds significant roles as Director and Managing Director of BIO-key HK.
• This transaction indicates an ongoing commitment of a key director and officer to the company's future.

Negatives

• The grant price of $0 indicates non-cash compensation, which, while standard for restricted stock, can lead to dilution of existing shareholders if not managed effectively over time.

Risks

• The vesting of the restricted stock is subject to the reporting person's continued employment or service, posing a risk if Mr. Wong departs before the full vesting period is complete.
• Future issuances under stock incentive plans, while beneficial for employee retention, carry the inherent risk of potential dilution for existing shareholders if not prudently managed.

Future Outlook

The grant of restricted stock with a multi-year vesting schedule suggests the company's intention to retain key management and align their incentives with long-term performance, indicating a stable outlook for executive leadership and a focus on sustained growth.

Industry Context

Restricted stock grants are a common and widely accepted form of executive compensation in the technology and software industry, particularly for companies like BIO-key International that rely on specialized talent. This practice helps align management incentives with long-term company performance and shareholder value, a standard across many publicly traded companies.

Comparison to Industry Standards

• The grant of restricted stock with a three-year vesting schedule is a standard practice for executive compensation in the technology sector, comparable to compensation structures seen at companies like IdentityX, Okta, or Ping Identity, which also utilize equity incentives to attract and retain key talent and align their interests with long-term company growth.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential minor dilution from the issuance of new shares, but also benefit from improved management alignment and retention, which can contribute to long-term value creation.
• Employees: This executive compensation practice can reflect the company's overall philosophy on equity incentives, potentially impacting morale and retention across the organization.

Next Steps

• The 2,000 restricted shares will continue to vest in three equal annual installments on the anniversaries of the grant date.
• Mr. Wong's continued employment or service to the Issuer is required for the vesting of these shares.

Key Dates

Recommendation

Keywords

BIO-KEY INTERNATIONAL, BKYI, Form 4, SEC filing, insider transaction, restricted stock, stock incentive plan, executive compensation, corporate governance, Kwok Fong Wong